OTC · Financial Statements

Lifeline Biotechnologies, Inc. (LLBO) Financial Statements

$0.00 OTC: LLBO Market Cap $2.17M

Lifeline Biotechnologies, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20182022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20182022202320242025
Total Assets$0————
Total Liabilities$0————
Cash$0————
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20182022202320242025
Operating Cash Flow$0————
Investing Cash Flow$0————
Financing Cash Flow$0————
Net Cash Flow$0————
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.37
EV / EBITDA-37.30
FCF Yield0.00%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y300.00%
Return 3Y33.33%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
LLBO Overview LLBO Dividend Run Stock Screener